cancer therapy
cancer therapy
Revolutionary Cancer Treatment: Lonza and Qurient Unite!
🌟 Lonza's Synaffix and Qurient Therapeutics unite for dual-payload ADCs, enhancing cancer treatment with innovative cytotoxic agents! 💊🔬🚀
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
Breakthrough Cancer Treatment Targets Solid Tumors
📰 FDA approved first cancer therapy targeting solid tumors using tumor-infiltrating lymphocytes (TILs). Exciting potential for cancer treatment! 👩⚕️🦠🔍
Genmab’s $18bn Acquisition Boosts Cancer Pipeline
💥 Genmab is acquiring ProfoundBio for $1.8bn to expand its pipeline of antibody-drug conjugate therapies. 💊🏭🚀
Firefly Raises $94 Million to Revolutionize Cancer Treatment
🔥 Firefly secures $94m 💼 to develop antibody conjugates ⚡️ for precision medicines targeting cancer and other diseases. 🌍
Groundbreaking $800m Cancer Partnership Revolutionizes Treatment
🔍 Sorry, the requested page cannot be found. Please go back to the home page. 🏠 AstellasXyphos Kelonia CancerResearch Partnership
Samsung Biologics and LegoChem unite to revolutionize cancer treatment
🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.
Revolutionary Kyverna Cuts CAR-T Production to 3 Days
📰 CAR-T, a gamechanger in cancer treatment, could revolutionize patient access and save lives with Kyverna's 3-day process. 💉🔬
Accelerating ADC Development and Manufacturing: Streamlining Solutions
📰 ADC Development and Manufacturing: Simplify, Derisk, and Accelerate the Timeline tackles challenges and offers solutions for ADC development and manufacturing. 🧬🔬🎯
